SHANGHAI – China says it will launch a three-month crackdown on commercial bribery with a particular focus on drug sales, distribution and medical services in a drive that could be a prelude to wider reforms in the health care system.
China’s enforcement agency on commercial practices, the State Administration for Industry and Commerce (SAIC), began a three-month investigation Aug. 15 that will run to the end of November. SAIC is...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?